Status:
COMPLETED
Daily Dose Estimation of Jarlsberg Cheese in Healthy Norwegian Elderly Male and Female
Lead Sponsor:
Meddoc
Collaborating Sponsors:
Tine
Conditions:
Healthy Aging
Eligibility:
All Genders
65-80 years
Phase:
NA
Brief Summary
Aim: To estimate OED of Jarlsberg cheese and the stabilized level of serum Osteocalcin in healthy elderly men and women. Study population consists of healthy men at least 65 years old and healthy pos...
Detailed Description
Aim: To estimate OED of Jarlsberg cheese and the stabilized level of serum Osteocalcin in healthy elderly men and women. Study population consists of healthy men at least 65 years old and healthy pos...
Eligibility Criteria
Inclusion
- Healthy post-menopausal women and men passed the age of 65years
Exclusion
- \- Known gastrointestinal disorder
- Abnormal liver or kidney function.
- Diabetes
- Suffering from verified cancer
- Under systemic treatment with corticosteroids or other immunosuppressive drugs the last 3 weeks before start of the trial treatment.
- LDL-cholesterol \> 3 mmol/L or Triglyceride \> 2 mmol/l
- Participating in another clinical trial with pharmaceuticals the last six weeks before start of this trial treatment.
- Lactose intolerance or known milk product allergy
- Not able to understand information.
- Do not want or not able to give written consent to participate in the study.
Key Trial Info
Start Date :
January 19 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05434806
Start Date
January 19 2023
End Date
June 15 2023
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skjetten Medical Center
Skjetten, Norway, 2013